[go: up one dir, main page]

TW201611830A - Pharmaceutical formulation for reducing bladder spasms and method of use thereof - Google Patents

Pharmaceutical formulation for reducing bladder spasms and method of use thereof

Info

Publication number
TW201611830A
TW201611830A TW104114896A TW104114896A TW201611830A TW 201611830 A TW201611830 A TW 201611830A TW 104114896 A TW104114896 A TW 104114896A TW 104114896 A TW104114896 A TW 104114896A TW 201611830 A TW201611830 A TW 201611830A
Authority
TW
Taiwan
Prior art keywords
bladder spasms
pharmaceutical formulation
reducing bladder
effective amount
reducing
Prior art date
Application number
TW104114896A
Other languages
Chinese (zh)
Other versions
TWI618535B (en
Inventor
David A Dill
Original Assignee
Wellesley Pharmaceuticals Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/495,134 external-priority patent/US20150010599A1/en
Application filed by Wellesley Pharmaceuticals Llc filed Critical Wellesley Pharmaceuticals Llc
Publication of TW201611830A publication Critical patent/TW201611830A/en
Application granted granted Critical
Publication of TWI618535B publication Critical patent/TWI618535B/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Methods and compositions for reducing bladder spasms are disclosed. The methods comprise administering to a subject in need thereof a pharmaceutical composition comprising an effective amount of acetaminophen and an effective amount of at least one non-steroidal anti-inflammatory drug (NSAID). In another embodiment, a method for reducing bladder spasms comprising administering to a subject in need thereof a pharmaceutical composition comprising an effective amount of at least one prostaglandin (PG) pathway inhibitor, wherein the at least one PG pathway inhibitor is not acetaminophen or an NSAID.
TW104114896A 2014-09-24 2015-05-11 Pharmaceutical formulation for reducing bladder spasms and method of use thereof TWI618535B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/495,134 US20150010599A1 (en) 2010-07-08 2014-09-24 Pharmaceutical formulation for reducing bladder spasms and method of use thereof
US14/495,134 2014-09-24

Publications (2)

Publication Number Publication Date
TW201611830A true TW201611830A (en) 2016-04-01
TWI618535B TWI618535B (en) 2018-03-21

Family

ID=56360653

Family Applications (1)

Application Number Title Priority Date Filing Date
TW104114896A TWI618535B (en) 2014-09-24 2015-05-11 Pharmaceutical formulation for reducing bladder spasms and method of use thereof

Country Status (2)

Country Link
AR (1) AR100515A1 (en)
TW (1) TWI618535B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112704727A (en) * 2021-01-12 2021-04-27 重庆医科大学附属第二医院 Application of terlipressin in preparation of medicine for treating dynamic ileus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006249684A1 (en) * 2005-05-20 2006-11-30 Omeros Corporation Cyclooxygenase inhibitor and calcium channel antagonist compositions and methods for use in urological procedures

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112704727A (en) * 2021-01-12 2021-04-27 重庆医科大学附属第二医院 Application of terlipressin in preparation of medicine for treating dynamic ileus
CN112704727B (en) * 2021-01-12 2023-05-16 重庆医科大学附属第二医院 Application of terlipressin in preparation of medicament for dynamic intestinal obstruction

Also Published As

Publication number Publication date
AR100515A1 (en) 2016-10-12
TWI618535B (en) 2018-03-21

Similar Documents

Publication Publication Date Title
MX2017004906A (en) Dihydropyrrolopyridine inhibitors of ror-gamma.
MY196909A (en) Boronic acid derivatives and therapeutic uses thereof
MY196173A (en) Cot Modulators And Methods Of Use Thereof
CL2015002164A1 (en) Combined formulation of two antiviral compounds.
PH12016500649A1 (en) Combinations of histone deactylase inhibitors and immunomodulatory drugs
MX2016011810A (en) Pharmaceutical compositions of therapeutically active compounds.
PH12016501830A1 (en) Inhibitors of c5a for the treatment of viral pneumonia
BR112016022062A8 (en) combination, pharmaceutical composition, use of a combination or a pharmaceutical composition, and pharmaceutical product
BR112016028845A2 (en) compound, pharmaceutical composition and use of a compound
MX383254B (en) COMBINATION COMPRISING A GLUCOCORTICOID AND EDO-S101.
HK1231390A1 (en) Pharmaceutical composition for topical administration
WO2014153495A3 (en) Novel stat3 inhibitors
AU2016204294A1 (en) Solid State Forms Of A Quinazoline Derivative And Its Use As A BRAF Inhibitor
NZ735777A (en) Methods and compositions to inhibit symptoms associated with veisalgia
MX2017013137A (en) Chromene derivatives as phoshoinositide 3-kinases inhibitors.
EP4406969A3 (en) Use of il-17 antagonists to inhibit the progression of structural damage in psoriatic arthritis patients
MX2016016039A (en) PHARMACEUTICAL FORMULATION TO REDUCE THE FREQUENCY OF MICTION AND METHOD FOR USE ..
MX2016011025A (en) GRAPIPRANT COMPOSITIONS AND METHODS TO USE THE SAME.
CR20160353A (en) CHOLESTERILE ESTER TRANSFER PROTEIN INHIBITOR (CETP) AND PHARMACEUTICAL COMPOSITIONS UNDERSTANDING THE INHIBITOR FOR USE IN THE TREATMENT OR PREVENTION OF CARDIOVASCULAR DISEASES
ECSP16086232A (en) (R) -PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE
ECSP15050273A (en) ORAL FORMULATION FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
MX2017003878A (en) Pharmaceutical formulation for reducing bladder spasms and method of use thereof.
TW201611830A (en) Pharmaceutical formulation for reducing bladder spasms and method of use thereof
MX2014005153A (en) Production method and sublingual pharmaceutical composition of ketorolac tromethamine and tramadol hydrochloride used for pain.
WO2019132729A3 (en) Indomethacin menthyl ester-based pharmaceutical compositions and use thereof

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees